SCHEMBL10282811

SCHEMBL10282811

CC(C)(C)OC(=O)N1CCN(Cc2cn3c(-c4ccccc4N=O)csc3n2)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 5/20 0.42
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KDM1A O60341 4/20 0.38
SMARCA2 P51531 1/20 0.37
SMARCA4 P51532 1/20 0.37
PBRM1 Q86U86 1/20 0.37
KDM1B Q8NB78 1/20 0.36
PIK3CD O00329 2/20 0.36
TERT O14746 1/20 0.36
GBA1 P04062 1/20 0.35
PARP1 P09874 1/20 0.35
DTYMK P23919 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220290 0.88 SMARCA2 (0.44) ACKR3CHRM2CHRM4CHRM1CHRM3
SCHEMBL27714533 0.73 SMN1; SMN2 (0.35) KDM4EALDH1A1
SCHEMBL220889 0.71 SIRT1 (0.47) ACKR3CHRM2CHRM4CHRM1CHRM3
SCHEMBL21579067 0.71 ACKR3 (0.49) ACKR3CHRM2CHRM4CHRM1CHRM3
SCHEMBL22221684 0.71 ACKR3 (0.71) ACKR3CHRM2CHRM4CHRM1CHRM3
SCHEMBL27923722 0.71 ALDH1A1 (0.35) KDM4EALDH1A1
SCHEMBL2734028 0.69 ALDH1A1 (0.60) ACKR3CHRM2CHRM4CHRM1CHRM3
Tert-Butyl Formate SCHEMBL27714534 0.68 SIRT1 (0.39) CHRM2CHRM1KDM4EALDH1A1
SCHEMBL465777 0.68 SMN1; SMN2 (0.51) ACKR3CHRM2CHRM4CHRM1CHRM3
SCHEMBL16061780 0.68 FAAH (0.58) ACKR3CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093401-B2 Silent Information Regulators; aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting , increased mitochondrial activity, inflammation, cancer, and/or flushing; increased lifespan specially in mutant sir2 strains; imidazo[1,2-a]pyridine drivatives SIRTRIS PHARMACEUTICALS, INC. (US) 2012-01-10 US disclosed
US-7855289-B2 histone deacetylase inhibitors, used for treating preventing diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood disorders, inflammation, cancer, and/or hot flashes SIRTRIS PHARMACEUTICALS, INC. (US) 2010-12-21 US disclosed